These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18477275)

  • 21. Prevention and Management of Adverse Reactions Induced by Iodinated Contrast Media.
    Wu YW; Leow KS; Zhu Y; Tan CH
    Ann Acad Med Singap; 2016 Apr; 45(4):157-64. PubMed ID: 27292007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity of contrast media: an update.
    ten Dam MA; Wetzels JF
    Neth J Med; 2008 Nov; 66(10):416-22. PubMed ID: 19011267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse reactions after intravascular iodinated contrast media administration and their management.
    Rašiová M; Schlager O; Heiss C; Brodmann M; Olinic DM; Boc V; Buso G; Belch J; Mazzolai L; Madaric J
    Vasa; 2024 May; 53(3):193-203. PubMed ID: 38651340
    [No Abstract]   [Full Text] [Related]  

  • 24. CE: Preventing Contrast-Induced Acute Kidney Injury.
    Gallegos Y; Taha AA; Rutledge DN
    Am J Nurs; 2016 Dec; 116(12):38-45. PubMed ID: 27831955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for the prevention of contrast-induced acute kidney injury.
    Weisbord SD; Palevsky PM
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):539-49. PubMed ID: 20625289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proposal of a skin tests based approach for the prevention of recurrent hypersensitivity reactions to iodinated contrast media.
    Della-Torre E; Berti A; Yacoub MR; Guglielmi B; Tombetti E; Sabbadini MG; Voltolini S; Colombo G
    Eur Ann Allergy Clin Immunol; 2015 May; 47(3):77-85. PubMed ID: 25951145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basics of prevention and management of iodine-based contrast media-induced thyroid dysfunction - position paper by the Polish Society of Endocrinology.
    Bednarczuk T; Kajdaniuk D; Marek B; Bolanowski M; Dedecjus M; Gilis-Januszewska A; Hubalewska-Dydejczyk A; Jarząb B; Junik R; Kamiński G; Kos-Kudła B; Kowalska A; Lewiński A; Matyjaszek-Matuszek B; Ruchała M; Siemińska L; Sworczak K; Syrenicz A; Zgliczyński W
    Endokrynol Pol; 2023; 74(1):1-4. PubMed ID: 36847719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immediate allergy to iodinated contrast agents and prevention of reactions].
    Dewachter P; Mouton-Faivre C; Laroche D; Clément O
    Rev Med Interne; 2009 Oct; 30(10):872-81. PubMed ID: 19375199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
    ACT Investigators
    Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-Induced Nephropathy: Identifying the Risks, Choosing the Right Agent, and Reviewing Effective Prevention and Management Methods.
    Nicola R; Shaqdan KW; Aran K; Mansouri M; Singh A; Abujudeh HH
    Curr Probl Diagn Radiol; 2015; 44(6):501-4. PubMed ID: 26072134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast media controversies in 2015: imaging patients with renal impairment or risk of contrast reaction.
    Davenport MS; Cohan RH; Ellis JH
    AJR Am J Roentgenol; 2015 Jun; 204(6):1174-81. PubMed ID: 25730301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-induced nephropathy.
    Marenzi G; Cabiati A; Milazzo V; Rubino M
    Intern Emerg Med; 2012 Oct; 7 Suppl 3():S181-3. PubMed ID: 23073854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
    Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
    Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iodinated Contrast Media and the Alleged "Iodine Allergy": An Inexact Diagnosis Leading to Inferior Radiologic Management and Adverse Drug Reactions.
    Böhm I; Nairz K; Morelli JN; Keller PS; Heverhagen JT
    Rofo; 2017 Apr; 189(4):326-332. PubMed ID: 28249309
    [No Abstract]   [Full Text] [Related]  

  • 35. [Guideline 'Precautionary measures for contrast media containing iodine'].
    van Dijk Azn R; Wetzels JF; ten Dam MA; Aarts NJ; Schimmelpenninck-Scheiffers ML; Freericks MP; Said SA; Geenen RW; Stuurman A; van Everdingen JJ
    Ned Tijdschr Geneeskd; 2008 Mar; 152(13):742-6. PubMed ID: 18461890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
    Birck R; Krzossok S; Markowetz F; Schnülle P; van der Woude FJ; Braun C
    Lancet; 2003 Aug; 362(9384):598-603. PubMed ID: 12944058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Contrast-induced nephropathy].
    Krummel T; Faller AL; Bazin D; Hannedouche T
    Presse Med; 2010; 39(7-8):807-14. PubMed ID: 20462732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contrast-induced nephropathy].
    Humbert A; Kissling S; Teta D
    Rev Med Suisse; 2013 Jun; 9(389):1222-8. PubMed ID: 23798193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute Kidney Injury and Iodinated Contrast Media.
    Matthews E
    Radiol Technol; 2018 May; 89(5):467CT-477CT. PubMed ID: 29793919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.